Government Context

Documents Documents by topic Documents by agency Pricing Log in Create account

Login Create account

FDA-2003-P-0404

FDA-2003-P-0404

Documents

4

Total comments

0

all analyzed

Comment status

Closed

Last activity

—

In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

All 4 Other 3 Notice 1

📄 Primary document

OtherJun 27, 2005

Letter from FDA CDER to Lachman Consultant Services, Inc.

Closed on Jun 22, 2005

Notice· Jun 22, 2005
Determination That PYRIDOSTIGMINE BROMIDE Tablets, 30 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness→
Closed on Jun 22, 2005
Other· May 12, 2004
Letter from FDA CDER to Lachman Consultant Services, Inc.→
No comment period
Other· Oct 30, 2003
Acknowledgment Letter from FDA DMB to Lachman Consultant Services, Inc.→
No comment period